UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-QSB

Quarterly Report Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

For the quarterly period ended March 31, 2005

Commission file Number 00114800

CYTATION CORPORATION

(Exact Name of Registrant as Specified in its Charter)



|Delaware                                       | 16-0961436                             
|---------------------------------------------- | ---------------------------------------
|(State or Other Jurisdiction of Incorporation) | (I.R.S. Employer Identification
Number)

251 Thames Street, No. 8, Bristol, RI 02809 (Address of
Principal Executive Offices) (Zip Code)

(401) 254-8800 (Registrant's Telephone Number, Including
Area Code)

Indicate by check mark whether the registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days.

YES [X] NO [ ]

Indicate the number of shares outstanding of each of the issuer's classes of
common stock, as of the latest practical date:

Common Stock, $.001 Par Value - 437,831 shares as of May 12, 2005.



FORWARD-LOOKING INFORMATION

THIS FORM 10-QSB AND OTHER STATEMENTS ISSUED OR MADE FROM TIME TO TIME BY
CYTATION CORPORATION OR ITS REPRESENTATIVES CONTAIN STATEMENTS WHICH MAY
CONSTITUTE "FORWARD-LOOKING STATEMENTS" WITHIN THE MEANING OF THE SECURITIES ACT
OF 1933 AND THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED BY THE PRIVATE
SECURITIES LITIGATION REFORM ACT OF 1995. FIFTEEN U.S.C.A. SECTIONS 77Z-2 AND
78U-5 (SUPP. 1996). THOSE STATEMENTS INCLUDE STATEMENTS REGARDING THE INTENT,
BELIEF OR CURRENT EXPECTATIONS OF CYTATION CORPORATION AND MEMBERS OF ITS
MANAGEMENT TEAM AS WELL AS THE ASSUMPTIONS ON WHICH SUCH STATEMENTS ARE BASED.
PROSPECTIVE INVESTORS ARE CAUTIONED THAT ANY SUCH FORWARD-LOOKING STATEMENTS ARE
NOT GUARANTEES OF FUTURE PERFORMANCE AND INVOLVE RISKS AND UNCERTAINTIES, AND
THAT ACTUAL RESULTS MAY DIFFER MATERIALLY FROM THOSE CONTEMPLATED BY SUCH
FORWARD-LOOKING STATEMENTS. THE COMPANY UNDERTAKES NO OBLIGATION TO UPDATE OR
REVISE FORWARD-LOOKING STATEMENTS TO REFLECT CHANGED ASSUMPTIONS, THE OCCURRENCE
OF UNANTICIPATED EVENTS OR CHANGES TO FUTURE OPERATING RESULTS OVER
TIME.

LETTER OF INTENT TO MERGE

ON APRIL 8, 2005, THE COMPANY ENTERED INTO A BINDING LETTER OF INTENT WITH EVOLVE ONCOLOGY, INC. ("EVOLVE") (PINK SHEETS: "EVON") TO EFFECT A MERGER WITH
EVOLVE. THE COMPANY WILL BE THE SURVIVING CORPORATION. UNDER THE PROPOSED MERGER, THE COMPANY WOULD AUTHORIZE ADDITIONAL SHARES OF COMMON STOCK TO BE ISSUED IN THE TRANSACTION,
DECLARE A 2.5 FOR ONE FORWARD STOCK SPLIT, AND ISSUE TO EVOLVE'S STOCKHOLDERS APPROXIMATELY 20,800,000 NEWLY ISSUED SHARES OF ITS COMMON STOCK. EVOLVE AGREED TO ASSUME AND TO PAY
APPROXIMATELY $115,000 OF THE COMPANY'S LIABILITIES AT THE CLOSING OF THE TRANSACTION. AFTER THE TRANSACTION, STOCKHOLDERS OF EVOLVE WOULD OWN APPROXIMATELY 95% OF THE TOTAL ISSUED
AND OUTSTANDING COMMON STOCK OF THE COMPANY.

UPON THE CLOSING OF THIS TRANSACTION, THE CURRENT OFFICERS AND DIRECTORS OF THE COMPANY WILL RESIGN. EVEN THOUGH THE COMPANY WILL BE THE SURVIVING CORPORATION IN THE MERGER, THE
COMPANY WILL BE ENGAGED IN A COMPLETELY DIFFERENT BUSINESS WITH NEW MANAGEMENT AND DIRECTORS. CURRENT STOCKHOLDERS OF THE COMPANY WILL ONLY OWN A 5% OF THE MERGED BUSINESS
INITIALLY, WHICH OWNERSHIP COULD BE FURTHER DILUTED IN THE EVENT THAT THE COMPANY, AFTER THE MERGER, ISSUES ADDITIONAL EQUITY TO RAISE CAPITAL OR FOR ACQUISITIONS.



PART 1 FINANCIAL INFORMATION

Item 1. Financial Statements.

Cytation Corporation

CONTENTS

UNAUDITED FINANCIAL STATEMENTS

Balance Sheets as of March 31, 2005 and December 31,
2004     Statements of Operations for the Three
Months Ended March 31, 2005 and
2004

---

Cytation
      CorporationBalance
      SheetsASSETSMarch 31,
    
    December 31,2005
    
    2004(Unaudited)
    
    (Audited)CURRENT
      ASSETS:Cash
    $
    21,719
    $
    62,707Marketable
      securities, at market value
    
    -
    
    2,937Notes receivable,
      stockholders
    
    10,112
    
    10,112Notes receivable,
      others
    
    -
    
    5,000Prepaid expenses and
      other current assets
    
    272
    
    8,706Total
      Current Assets
    
    32,103
    
    89,462PROPERTY
      AND EQUIPMENT, Net
    
    4,596
    
    4,496OTHER
      ASSETS:Security
      deposit
    
    1,800
    
    1,800Investment in
      privately-held companies
    
    54,718
    
    59,71856,518
    
    61,518TOTAL
      ASSETS
    $
    93,217
    $
    155,476==========
    
    ==========LIABILITIES AND
      STOCKHOLDERS' EQUITYCURRENT
      LIABILITIES:Accounts payable and
      accrued expenses
    $
    42,555
    $
    92,306Note payable and
      accrued interest
    
    121,612
    
    120,227Total
      Current Liabilities
    
    164,167
    
    212,533COMMITMENTS AND CONTINGENCIES
    
    -
    
    -STOCKHOLDERS' EQUITY:Common stock, $0.001
      par value, 2,000,000 shares authorized,437,831
      and 436,165 shares issued and outstanding, respectively
    438
    
    436Additional paid-in
      capital
    
    32,608,449
    
    32,608,451Shares subscribed but
      not issued (23,500 shares)
    
    23,500
    
    -Accumulated
      deficit
    
    (32,703,337)
    
    (32,665,944)TOTAL
      STOCKHOLDERS' EQUITY
    
    (70,950)
    
    (57,057)TOTAL
      LIABILITIES AND STOCKHOLDERS' EQUITY
    $
    93,217
    $
    155,476===========
    
    ==========See notes to financial
      statements.


---



Cytation
      CorporationStatements of
      OperationsFor The Three
      Months Ended March 31, 2005 and 2004(Unaudited)2005
    
    2004CONSULTING
      REVENUE
    $
    -
    $
    5,000COST OF
      REVENUE
    
    1,182
    
    445,405GROSS
      PROFIT
    
    (1,182)
    
    (440,405)OPERATING
      EXPENSES:Depreciation
    
    512
    
    804Selling, general and
      administrative
    
    28,810
    
    109,179TOTAL
      OPERATING EXPENSES
    
    29,322
    
    109,983OPERATING
      LOSS
    
    (30,504)
    
    (550,388)OTHER INCOME
      (EXPENSES)Gain on sale of
      investment
    
    
    
    
    266,250Loss on termination
      of ARE agreement
    
    (5,000)
    
    -Interest income
      (expenses), net
    
    (1,889)
    
    (1,386)TOTAL
      OTHER INCOME (EXPENSES)
    
    (6,889)
    
    264,864(LOSS)
      INCOME BEFORE INCOME TAXES
    
    (37,393)
    
    (285,524)INCOME
    TAXES
    
    -
    
    -NET
      LOSS
    $
    (37,393)
    $
    (285,524)==========
    
    ===========Net (Loss) Income
      Per Share (Basic and Diluted)
    $
    (0.09)
    $
    (0.98)==========
    
    ===========Weighted Average
      Common Shares Outstanding
    
    436,998
    
    292,776==========
    
    ===========See notes to financial
  statements.


---



Cytation
      CorporationStatements
      of Cash FlowsFor The
      Three Months Ended March 31, 2005 and 2004(Unaudited)2005
    
    2004CASH FLOWS FROM OPERATING ACTIVITIES:Net loss
    $
    (37,393)
    $
    (285,524)Adjustments to
      reconcile net loss to net cashused
      in operating activities:Depreciation
    
    512
    
    804Gain
      on sale of investment
    
    -
    
    (266,250)Stock
      based compensation
    
    -
    
    72,000Accrued
      interest on note payable
    
    1,385
    
    1,386Loss
      on termination of ARE agreement
    
    5,000
    
    -Non-cash
      consulting income
    
    -
    
    (5,000)Non-cash
      consulting fee
    
    
    
    443,750Changes in operating
      assets and liabilities:Prepaid expenses and othersPrepaid
      expenses and others
    
    8,434
    
    -Accounts
      payable and accrued expenses
    
    (49,751)
    
    27,222NET
      CASH USED IN OPERATING ACTIVITIES
    (71,813)
    
    (11,612)CASH FLOWS USED IN INVESTING ACTIVITIES:Purchases of property
      and equipment
    
    (612)
    
    -CASH FLOWS FROM FINANCING ACTIVITIES:Collections of notes
      receivable
    
    5,000
    
    10,000Proceeds from
      issuance of common stock
    
    23,500
    
    25NET
      CASH PROVIDED BY FINANCING ACTIVITIES
    
    28,500
    
    10,025NET
      DECREASE (INCREASE) IN CASH
    
    (43,925)
    
    (1,587)CASH, Beginning
    
    65,644
    
    2,236CASH, Ending
    $
    21,719
    $
    649=========
    
    =========SUPPLEMENTAL DISCLOSURE OF CASH FLOW
      INFORMATION:Cash paid during the
      periods for:Interest
    $
    828
    $
    -=========


    =========Taxes
    $
    -
    $
    -=========
    
    =========See notes to financial
      statements.


---

Notes to Financial Statements

1.  Basis of Presentation

The accompanying unaudited financial statements of Cytation Corporation (the
"Company") have been prepared in accordance with generally accounting principles
for interim financial information and with the instructions to prepare them for
inclusion as part of the Form 10QSB. Accordingly, they do not include all of the
information and footnotes required by generally accepted accounting principles
for complete financial statements. The financial statements for the periods
ended March 31, 2005 and 2004 are unaudited and include all adjustments which in
the opinion of management, are necessary in order to make the financial
statements not misleading. All such adjustments are of a normal recurring
nature. The results of the Company's operations for any interim period are not
necessarily indicative of the results of the Company's operations for a full
year. For further information, refer to the financial statements and footnotes
thereto included in the Company's Form 10KSB filed with the Securities and
Exchange Commission for the period ended December 31, 2004.

2.  The Company

Until June 20, 2001, the Company provided an extensive range of in-school and
online services directed at high school students and their parents, high school
counselors, college admissions officers and corporations which target with the
teen marketplace. On June 20, 2001, the Company sold all of its assets
associated with these activities to TMP Worldwide Inc. for approximately $7.2
million in cash and debt assumed.

During the period commencing with the fourth quarter of 2002 and ending in
December 2004, the Company engaged in the business of providing consulting and
related services to private companies that wish to become reporting companies
under the Securities Exchange Act of 1934. In the first quarter of 2005, the
Company discontinued all business operations and agreed to engage in a reverse
merger transaction. See "Subsequent Events".

3.  Equity Transactions

On February 14, 2005, the Company authorized the issuance for no
consideration of 1,666 shares to Bost &Co., an unaffiliated third party, in
consideration of a prior investment. On March 4, 2004,

4.  Investment/Termination of Consulting Agreement

In the first quarter of 2004, the Company received 500,000 restricted shares
of common stock and warrants of an unrelated entity, American Radio Empire, Inc.
("ARE"), as compensation for the consulting services provided and to be
provided. The investment was valued at $5,000, which management believes is
approximately the fair value of the shares at this time, and this amount was
recorded as consulting revenue on the accompanying financial statements. During
the first quarter of 2005, the Company returned the 500,000 restricted shares of
ARE common stock and entered into a mutual release agreement with ARE pursuant
to which each party released all claims against the other.

5.  Subsequent Events

During the first quarter of 2005, the Company reviewed business opportunities
resulting from its status as a Business Development Company under the Investment
Company Act of 1940 and evaluated other courses of action. On April 8, 2005, the
Company entered into a binding letter of intent with Evolve Oncology, Inc.
("Evolve") to effect a merger with Evolve pursuant to which the Company will not
engage in any further business operations other than to close the merger
transaction. Although the Company will be the surviving corporation under the
proposed merger, it will not thereafter engage in any business that it has
engaged in the past. Stockholders of the Company will be substantially diluted,
and the Company's current officers and directors will resign. The Company will
authorize additional shares of common stock to be issued in the transaction,
declare a 2.5 for one forward stock split, and issue to Evolve's stockholders
approximately 20,800,000 newly issued shares of its common stock. Evolve has
agreed to assume and to pay approximately $115,000 of the Company's liabilities
at the closing of the transaction. After the transaction, stockholders of Evolve
would own approximately 95% of the total issued and outstanding common stock of
the Company.

Evolve is developing products for the treatment of breast cancer, leukaemia
and multiple cancer treatments including lymphomas, melanomas and gastric
cancer.

On February 14, 2005, the Company authorized the issuance of 15,000 shares to
Richard Parke in consideration of his agreement to join the Company's board of
directors. The purchase price of these shares was $15.00. On March 4, 2004, the
Company agreed to issue 23,500 of its common shares to an unaffiliated third
party for $23,500. These shares (a total of 38,500) of common stock were issued
subsequent to March 31, 2005, and were not considered issued and outstanding as
of that date.

Item 2.  Management's Discussion and Analysis or Plan of
Operation.Results of Operations

As a result of the Company's decision to discontinue all business operations
and enter into a reverse merger transaction, the Company no longer is engaged in
any business in which it was engaged during its last three fiscal years.
Accordingly, management does not believe that it is informative or useful to
compare the results of operations of its former principal business with the
results of operations during the first quarter of 2005, when its decided to
terminate its business and engage in a reverse merger transaction.

Liquidity and Capital Resources As of March 31, 2005, we had
negative working capital of $132,064 compared to positive working capital of
$1,088,603 as of March 31, 2004.

We have minimal fixed expenses and minimal operating costs. We expect to be
able to operate until the closing of the merger with Evolve without generating
any revenue. In the event that the merger with Evolve does not occur, we expect
to be able to operate until the closing of another similar transaction. Our
officers serve as consultants to us and are not paid. We occupy our office space
on a month-to-month basis. The Company has no employment or consulting
agreements or long-term commitments for office space or services.

Item 3.  Controls and Procedures

As required by Rule 13a-15 under the Exchange Act, as of the end of the
period covered by this report for the quarter ended March 31, 2005, we have
carried out an evaluation of the effectiveness of the design and operation of
our disclosure controls and procedures. This evaluation was carried out under
the supervision and with the participation of our management, including our
President along with our Chairman and General Counsel. Based upon that
evaluation, our President along with our Chairman and General Counsel concluded
that our disclosure controls and procedures are effective as at the end of the
period covered by this report. There have been no significant changes in our
internal controls or in other factors, which could significantly affect internal
controls subsequent to the date we carried our evaluation.

Disclosure controls and procedures and other procedures that are designed to
ensure that information required to be disclosed in our reports filed or
submitted under the Exchange Act is recorded, processed, summarized and
reported, within the time period specified in the Securities and Exchange
Commission's rules and forms. Disclosure controls and procedures include,
without limitation, controls and procedures designed to ensure that information
required to be disclosed in our reports filed under the Exchange Act is
accumulated and communicated to management, including our President and Chairman
and General Counsel, as appropriate, to allow timely decisions regarding
required disclosure.

PART II OTHER INFORMATION

Item 1.  Legal Proceedings.

None.

Item 2.  Change in Securities.

On February 14, 2005, the Company authorized the issuance of 15,000 shares to
Richard Parke in consideration of his agreement to join the Company's board of
directors. The purchase price of these shares was $15.00. On February 14, 2005,
the Company authorized the issuance for no consideration of 1,666 shares to Bost
&Co., an unaffiliated third party, in consideration of a prior investment.
On March 4, 2004, the Company agreed to issue 23,500 of its common shares to an
unaffiliated third party for $23,500. None of these shares of common stock had
been issued as March 31, 2005, and only 1,666 of these shares are considered
issued and outstanding as of that date.



Item 3. Defaults Upon Senior Securities.

None.

Item 4. Submission of Matters to a Vote of Security Holders.

None.

Item 5. Other Information.

Certification under Sarbanes-Oxley Act.  Our president and our
chairman of the board and chief financial officer have furnished to the SEC the
certification with respect to this Report that is required by Section 906 of the
Sarbanes-Oxley Act of 2002. Item 6.  Exhibits and Reports
on Form 8-K.

(a)  Exhibits:

The following exhibits are filed as part of or incorporated by reference into
this Report:



|Exhibit | Description                                                                                                                                                                                                     
|------- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|3.1     | Amended and Restated Certificate of Incorporation of the
      Company(2)                                                                                                                                       
|3.2     | Articles of Merger between the Company and Cytation Corporation, dated
      February 11, 1999(1)                                                                                                               
|3.3     | Articles of Merger between CollegeLink.com Incorporated and ECI, Inc.,
      dated August 10, 1999(2)                                                                                                           
|3.4     | Certificate of Merger of CollegeLink.com Incorporated and ECI, Inc.,
      dated August 10, 1999(2)                                                                                                             
|3.5     | Certificate of Ownership and Merger between the Company and
      CollegeLink.com Incorporated, dated November 15, 1999(2)                                                                                      
|3.6     | By-Laws of the Company(2)                                                                                                                                                                                       
|4.1     | Please see Exhibits 3.1 and 3.6 for provisions of the Amended and
      Restated Certificate of Incorporation and By-Laws of the Company defining
      the rights of holders of the common stock of the Company
|10.1    | Consulting agreement dated March 18, 2004 by and between Business
      Solutions of the Future Inc. and the
Company                                                                                            

(1)  Incorporated
by reference from the Company's Form 8-K, Current Report, filed March 18, 1999,
and later
amended                  on April 2,
1999.           (2)  Filed
as Exhibit to the Company's Registration Statement No. 333-85079 on Form SB-2
and incorporated herein
                  by reference.

(b)   Reports on Form 8-K

Form 8K, Other Events, filed on April 11, 2005.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly
authorized.

CYTATION
CORPORATION

By: /s/Richard A. Fisher
                                    Name:
Richard A. Fisher
                                    Title:
Chairman of the Board and Chief Financial Officer

Date:  May 12, 2005